Cipla’s arm to incorporate JV Company in USA

06 Jan 2024 Evaluate

Cipla’s wholly owned subsidiary -- Cipla (EU) has entered into a joint venture agreement with Kemwell Biopharma UK and MNI Ventures, Mauritius on January 5, 2024 for incorporation of a joint venture (JV) company in USA. The JV entity is being incorporated with an objective of commercialising novel cell therapy products in USA, Japan and EU region.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.


Cipla Share Price

1496.35 -4.05 (-0.27%)
24-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1737.50
Dr. Reddys Lab 1266.35
Cipla 1496.35
Zydus Lifesciences 917.45
Lupin 2109.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×